Effect of alpha-adrenergic blockers on naloxone-binding in brain.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009270:Naloxone / Q000378:metabolism*; D009294:Narcotics / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D014316:Tritium
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D009294:Narcotics; D011955:Receptors, Drug; D014316:Tritium; D009270:Naloxone; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D011398:Promethazine